Article Text

other Versions

PDF
Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure
  1. Kathrin Rychli1,
  2. Bernhard Richter1,
  3. Philipp J Hohensinner1,
  4. Kariem Mahdy Ali1,
  5. Stephanie Neuhold1,
  6. Gerlinde Zorn1,
  7. Rudolf Berger1,
  8. Deddo Mörtl1,
  9. Kurt Huber2,
  10. Richard Pacher1,
  11. Johann Wojta1,
  12. Alexander Niessner1,
  13. Martin Hülsmann1
  1. 1Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
  2. 2Department of Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria
  1. Correspondence to Alexander Niessner, Department of Internal Medicine II, Division of Cardiology, Waehringer Guertel 18-20, 1090 Vienna, Austria; alexander.niessner{at}meduniwien.ac.at
  • Hepatocyte growth factor
  • angiogenesis
  • heart failure
  • cardiomyopathy
  • prognosis
  • cardiac remodelling
  • left ventricular hypertrophy
  • aortic valve disease
  • gene expression

Statistics from Altmetric.com

Footnotes

  • KR and BR contributed equally to this study.

  • Funding This work was supported by the Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology (Vienna, Austria) and by the Ludwig Boltzmann Foundation for Cardiovascular Research (Vienna, Austria).

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval This study was approved by the ethics committee of the Medical University of Vienna, Austria.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.